Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.

被引:0
|
作者
Goel, Vivek [1 ]
Malik, Manish [2 ]
Bhalla, A. K. [3 ]
机构
[1] Apollo Multispecialty Hosp, Nephrol, Kolkata, India
[2] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
[3] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
关键词
D O I
10.1097/01.tp.0001065280.60236.aa
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
305.7
引用
收藏
页数:1
相关论文
共 50 条
  • [21] AGE AND CYP3A5 GENOTYPE AFFECT TACROLIMUS DOSING REQUIREMENTS DIRECTLY AFTER TRANSPLANT IN PEDIATRIC HEART RECIPIENTS.
    Gijsen, V. M.
    Mital, S.
    van Schaik, R. H.
    Soldin, O. P.
    Soldin, S. J.
    van der Heiden, I. P.
    Nulman, I.
    Koren, G.
    de Wildt, S. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S34 - S34
  • [22] Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
    Qu, Lihui
    Lu, Yingying
    Ying, Meike
    Li, Bingjue
    Weng, Chunhua
    Xie, Zhoutao
    Liang, Ludan
    Lin, Chuan
    Yang, Xian
    Feng, Shi
    Wang, Yucheng
    Shen, Xiujin
    Zhou, Qin
    Chen, Ying
    Chen, Zhimin
    Wu, Jianyong
    Lin, Weiqiang
    Shen, Yi
    Qin, Jing
    Xu, Hang
    Xu, Feng
    Wang, Junwen
    Chen, Jianghua
    Jiang, Hong
    Huang, Hongfeng
    ONCOTARGET, 2017, 8 (46) : 81285 - 81294
  • [23] Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients
    Ferraresso, Mariano
    Tirelli, Amedea
    Ghio, Luciana
    Grillo, Paolo
    Martina, Valentina
    Torresani, Erminio
    Edefonti, Alberto
    PEDIATRIC TRANSPLANTATION, 2007, 11 (03) : 296 - 300
  • [24] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [25] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients
    Renders, L.
    Frisman, M.
    Ufer, M.
    Mosyagin, I.
    Haenisch, S.
    Ott, U.
    Caliebe, A.
    Dechant, M.
    Braun, F.
    Kunzendorf, U.
    Cascorbi, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 228 - 234
  • [26] Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
    Zong, Huiying
    Zhang, Yundi
    Liu, Fengxi
    Zhang, Xiaoming
    Yang, Yilei
    Cao, Xiaohong
    Li, Yue
    Li, Anan
    Zhou, Penglin
    Gao, Rui
    Li, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
    Hesselink, Dennis A.
    van Schaik, Ron H. N.
    van Agteren, Madelon
    de Fijter, Johannes W.
    Hartmann, Anders
    Zeier, Martin
    Budde, Klemens
    Kuypers, Dirk R. J.
    Pisarski, Przemyslav
    Le Meur, Yann
    Mamelok, Richard D.
    van Gelder, Teun
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (04): : 339 - 348
  • [28] Efficacy and Outcomes of CYP3A5 Genotype-Based Tacrolimus Dosing Compared to Conventional Body Weight-based Dosing in Living Donor Kidney Transplant Recipients
    Yashwanth Raj, T.
    Fernando, M. Edwin
    Prasad, NSrinivasa
    Sujit, S.
    Valavan, K. Thirumal
    Harshavardhan, T.
    Ramanathan, Arvind
    INDIAN JOURNAL OF NEPHROLOGY, 2022, 32 (03) : 240 - 246
  • [29] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618
  • [30] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618